Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:June 16, 2022 4:30...
AILERON THERAPEUTICS INC NASDAQ false 0001420565 0001420565 2022-06-15 2022-06-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION...
June 13, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E...
AILERON THERAPEUTICS INC NASDAQ false 0001420565 0001420565 2022-06-07 2022-06-07 UNITED STATES SECURITIES AND EXCHANGE COMMISSION...
Table of Contents As filed with the Securities and Exchange Commission on June 7, 2022...
AILERON THERAPEUTICS INC NASDAQ false 0001420565 0001420565 2022-06-05 2022-06-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION...
Aileron is developing ALRN-6924 to protect patients with p53 mutated cancers against chemotherapy-induced bone...
BOSTON, May 17, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology...
BOSTON, May 13, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology...
Taxanes, such as paclitaxel and docetaxel, cause severe and often permanent chemotherapy-induced hair loss...
On track to report interim results from Phase 1b clinical trial of ALRN-6924 in patients with advanced...
AILERON THERAPEUTICS INC NASDAQ false 0001420565 0001420565 2022-04-25 2022-04-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관
광고 없는 경험을 위해 가입하세요
지금 사용해 보세요
광고 유지